Covance Will Soon Be Labcorp Drug Development

We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.

Top 5 Design Considerations for Preclinical Immuno-oncology Studies

Contact Us

Killing Cancer Cells In Vitro is Not Enough

Can you anticipate the interplay between host animal and characteristics of the tumor model itself in immuno-oncology studies?

Scientists at Labcorp have run close to 1,000 preclinical immuno-oncology studies over the past five years, thoughtfully evaluating all aspects of study design.

Read our guide to learn about:

  • Modeling immuno-oncology in mouse models
  • Maximizing tumor placement for stromal-tumor interactions
  • Selecting a tumor model to test a checkpoint inhibitor
  • Plus more!

Let's start a conversation

Contact Us